Ledger.Open graph →

SEC Form D · filed November 21, 2024

Pep2Tango Therapeutics, Inc

Offering

$16.7M

Sold

$16.7M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

POTOMAC, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Steven J. Freidkin · POTOMAC, MDExec · Director Mickey Kim · Potomac, MDDirector Cristina Rondinone · Potomac, MDExec · Director Carlo Rizzuto · Potomac, MDDirector Soumitra Ghosh · Potomac, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗